TABLE 1.
Lung Cancer Diagnoses and Deaths in NLST
| CT | CXR | Total | |
|---|---|---|---|
| All participants in full NLST | 26,722 | 26,730 | 53,452 |
| With lung cancer diagnosis* | 1109 | 993 | 2102 |
| All exclusions from CEA | 80 | 70 | 150 |
| Lost to FU within 1 d | 46 | 54 | 100 |
| Missing lung cancer information | 33 | 15 | 48 |
| Less than 50 y of age | 1 | 1 | 2 |
| All participants in NLST CEA | 26,642 | 26,660 | 53,302 |
| With lung cancer diagnosis | 1076 | 978 | 2054 |
| All deaths | 1920 | 2044 | 3964 |
| Deaths from lung cancer† | 469 | 552 | 1021 |
| All deaths from other causes | 1451 | 1492 | 2943 |
| Deaths from other causes and lung cancer diagnosis |
49 | 35 | 84 |
| Alive‡ at end of trial | 24,722 | 24,616 | 49,338 |
| Alive‡ at end of trial with lung cancer diagnosis |
558 | 391 | 949 |
| Alive‡ at end of trial without lung cancer diagnosis |
24,164 | 24,225 | 48,389 |
Reprinted with permission from Black et al.6
The numbers are higher than those previously reported,2 because they include lung cancers diagnosed at time of death and a later data cut date (January 31, 2011 vs. September 28, 2010).
The numbers are higher than those previously reported,2 because they result from a later censor date (December 31, 2009 vs. January 15, 2009) and a later data cut date (January 31, 2011 vs. September 28, 2010).
Includes those lost to follow-up before December 31, 2009.
CXR indicates chest radiography; FU, follow-up.